Sell-Off Alert: HEXO (TSX:HEXO) Stock Is Down After CFO Quits

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) stock is falling after a key management change. Should you buy a key competitor instead?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This summer, pundits were asking themselves whether the share price of pot stock HEXO (TSX:HEXO)(NYSE:HEXO) was justified according to its fundamentals — a question not reserved just for HEXO.

Then HEXO’s chief brand officer and co-founder Adam Miron stepped down in July. The stock plunged, losing a fifth of its value.

Then on Friday, HEXO’s chief financial officer Michael Monahan threw in the towel. At close of play, the stock was down by a quarter of a percent, though this deepened quickly to a 4.2% loss by Friday evening in after-hours trading. Today has already seen the stock lose 6% at the time of writing.

Since Monahan only took the reins as CFO in June, investors may begin treating HEXO to a higher level of scrutiny, especially because it’s been such a short period of time since its previous management shake-up. However, Monahan cited personal reasons for standing down, and HEXO’s CEO and co-founder, Sebastien St-Louis, has praised his contribution to the business.

Cannabis bullishness prevails, but it’s a stock-picker’s market

This is one sector that doesn’t play nice with ETFs. While businesses in other sectors tend to move as one flock, such as banking or precious metals, cannabis is still too nebulous an industry for that. With companies pursuing a wide range of disparate corporate strategies, from deals with seemingly unrelated partners to business plans that depend on untried markets, the sector has yet to stabilize.

Already having ditched more than half its value from a year-long high of $11.29, HEXO could be looking at an even deeper sell-off after a change of staff that comes amid ratcheting uncertainty in the markets. Additionally, there’s always the possibility that HEXO could even become one of the first fairly large cannabis companies to be bought out entirely by a larger competitor.

Consider swapping out shares for this CBD market leader

In the meantime, cannabis investors looking to jump ship might want to reinvest in companies with more upside such as Charlotte’s Web Holdings. From high growth potential to a well-developed sense of branding, Charlotte’s Web is a stronger play than many other stocks in this space. Its operational space has grown by almost 300% since last year, with revenue leaping by 45%.

If you’re looking to jump on the CBD train, Charlotte’s Web is a good place to join. While some areas of the U.S. still look unfavourably upon hemp-based products, hemp growing became legal in the U.S. in December. This, along with a key deal with grocery giant Kroger, makes Charlotte’s Web an early industry leader in the CBD sector and a strong play for assured growth in a tried-and-tested market.

The bottom line

Companies with tried-and-tested business models, especially the ones most likely to become profitable ahead of the pack, are the best investments in this space. While HEXO may recover some of its losses, losing a high-ranking member of management is not usually a good sign. Charlotte’s Web remains a strong play, meanwhile, as the market is increasingly bullish on CBD growth, especially in the U.S.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »